On April 09, 2021, Swedish Medical Technologies Product (MTP) Council decided to add more technologies to the ongoing evaluation for self-monitoring of atrial fibrillation within the Orderly introduction framework, initiated in December 2020.
The Orderly introduction framework aimed to manage the national introduction of novel technologies is working as permanent from the beginning of 2020. This is a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation, and recommendations by MTP Council to regions about the introduction of the method and criteria for use.
In summer 2020, Swedish Dental and Pharmaceutical Benefits Agency (TLV) conducted a thematic survey in the cardiovascular area as a part of horizon scanning within the Orderly introduction framework, which provided information on products that the MTP Council has now found interesting to proceed with.
In December 2020, MTP Council commissioned the TLV to perform a health-economic evaluation of Coala Heart Monitor and KardiaMobile. As of early April 2021, the following products were added to the evaluation process: CardioMem CM 100 XT, PhysioMem PM 100, and Zenicor ECG. More technologies are expected to be added in the future.
Based on the results of the health-economic evaluation, the MTP Council will then make recommendations to the regions on whether to adopt these technologies or not.
See more details in Swedish here (MTP Council website) and here (TLV website).
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).